Drug Resistant Epilepsy: Clinical Trials

8 trials for Drug Resistant Epilepsy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown, 1 completed, 1 terminated. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Unknown 6, Completed 1, Terminated 1

Follow Drug Resistant Epilepsy: new trials by email Literature Review of Drug Resistant Epilepsy trials Research Report on Drug Resistant Epilepsy

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children
Valproic acid, Carbamazepin, Phenytoin - Drug Resistant Epilepsy
Phase 4UnknownDr Cipto Mangunkusumo General Hospital1002023-03-012023-01-26
Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic Outcomes
Fenfluramine - Refractory Epilepsy, SYNGAP1 Encephalopathy
Phase 4CompletedHospital Ruber Internacional202022-10-202026-09-29
Role of the Gut Microbiota in Pediatric Epilepsy
Prebiotic, Placebo - Drug Resistant Epilepsy
Phase 4UnknownBritish Columbia Children's Hospital452021-06-012022-03-09
Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
Anticonvulsant Agent, Perampanel, Quality-of-Life Assessment - Intractable Epilepsy, Malignant Glioma
Phase 4TerminatedMayo Clinic42020-12-042023-06-22
Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children
RiTUXimab Injection [Rituxan] - Refractory Epilepsy
Phase 4UnknownAssiut University1402020-10-012020-09-09
Comparison of Efficacy of LGIT and MAD Among Children With Drug Resistant Epilepsy
Low glycemic Index Therapy (LGIT), Modified Atkins Diet (MAD) - Drug Resistant Epilepsy, Ketogenic Dieting
Phase 4UnknownAll India Institute of Medical Sciences1102018-12-262019-09-10
Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy
clobazam (Onfi), Initial conversion and titration, Conversion schedule - Week 1 - Refractory Epilepsy
Phase 4UnknownSt. Joseph's Hospital and Medical Center, Phoenix212013-02-012017-03-03
The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy
Reduction of anti-epileptic medications, No drug change - Intractable Epilepsy
Phase 4UnknownInstitute of Child Health642008-09-012008-03-31

Narrower conditions

Epilepsy (4)  ·  Brain Diseases (1)  ·  Chromosome 15q, tetrasomy (1)  ·  Epileptic Encephalopathy, Early Infantile, 4 (1)  ·  Genetic Diseases, Inborn (1)  ·  Glioma (1)  ·  Nervous System Diseases (1)

Broader conditions

Central Nervous System Diseases (8)  ·  Brain Diseases (7)  ·  Nervous System Diseases (7)  ·  Epilepsy (4)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neuroectodermal Tumors (1)

Interventions

Clobazam (2)  ·  Adrenal Cortex Hormones (1)  ·  Anticonvulsants (1)  ·  Carbamazepine (1)  ·  Diet, Ketogenic (1)  ·  Fenfluramine (1)  ·  Lamotrigine (1)  ·  Oxcarbazepine (1)  ·  Phenytoin (1)  ·  Prebiotics (1)  ·  Rituximab (1)  ·  Trace Elements (1)  ·  Valproic Acid (1)  ·  perampanel (1)

Sponsors

All India Institute of Medical Sciences (1)  ·  Assiut University (1)  ·  British Columbia Children's Hospital (1)  ·  Dr Cipto Mangunkusumo General Hospital (1)  ·  Hospital Ruber Internacional (1)  ·  Institute of Child Health (1)  ·  Mayo Clinic (1)  ·  St. Joseph's Hospital and Medical Center, Phoenix (1)

Countries

United States (2)  ·  Canada (1)  ·  India (1)  ·  Indonesia (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Antonio Gil-Nagel, MD, PHD (1)  ·  Sheffali Gulati, MD (1)  ·  Steve Chung, MD (1)  ·  William Tatum (1)

Results publications

PMID 37609651